Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- Check2 days agoChange DetectedNew revision v3.6.2 has been added to the study documents section, and revision v3.6.0 has been removed. This reflects an update to the formal protocol and statistical analysis plan referenced on the page.SummaryDifference0.0%

- Check9 days agoChange DetectedNo additions or deletions were provided, so no changes to the page were detected. The page content remains as recorded.SummaryDifference0.0%

- Check16 days agoChange DetectedEnrollment status updated to indicate no further recruitment. New navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and expanded content for REVEAL Lite 2 risk-score endpoints have been added to the page.SummaryDifference0.6%

- Check23 days agoChange DetectedRevision: v3.5.5 was added, replacing the prior v3.5.4. This signals an updated version of the study documents on the page.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3, indicating a small update to the page version. There is no indication of substantive changes to study details or sections.SummaryDifference0.0%

- Check53 days agoChange DetectedThere are no recorded changes to summarize for this page. The provided data does not include additions or deletions to interpret in context.SummaryDifference0.0%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.